title: Outcomes of high-dose unilateral kidney irradiation in patients with gastric lymphoma.
abstract: OBJECTIVE
  To review the long-term clinical effects of unilateral kidney irradiation on overall renal function and blood pressure in patients with gastric lymphoma.
  
  
  METHODS
  In the study were 27 patients with Stage I or II gastric lymphoma who had undergone irradiation of at least 24 Gy to > or = 1/3 of the left kidney. They include 16 women and 11 men, aged 31 to 77, with a mean age of 57.6 years (median 56). Fifteen patients had Stage I and 12 had Stage II disease. In 13 patients the whole kidney had been irradiated, and 14 had had partial kidney irradiation, at doses ranging between 24 and 40.5 Gy. All patients received combined chemotherapy with various drugs: all patients received corticosteroids, and five received cis-platinum. Their follow-up ranged between 0.7 and 7.8 years (mean 3.4 years). Data on possible effects of the treatment on blood pressure, renal function as assessed by blood urea and creatinine, and kidney shrinkage as seen by serial computed tomography scanning were collected on all patients.
  
  
  RESULTS
  Three patients had persistent, mild elevations of urea and creatinine levels, which did not require special treatment. All three also received cis-platinum. Ipsilateral kidney shrinkage was evident in most patients. In 19 patients the craniocaudal measurement of the kidney shrank by > or = 1.6 cm. Shrinkage in other dimensions was also evident. The degree of atrophy was related to the volume of kidney irradiated. Only two patients developed hypertension, both at a low level of 150/90; one patient had had 40 Gy to the whole kidney, the other 40 Gy to half the kidney. Neither patient had elevated urea or creatinine.
  
  
  CONCLUSIONS
  Notwithstanding the shrinkage to the irradiated part of the kidney, the treatment did not lead to clinically significant hypertension or renal dysfunction. The administration of cis-platinum to patients with gastric lymphoma that requires kidney irradiation should be further evaluated.
authors.affiliation: Department of Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, Houston 77030, USA.
authors.forename: M H
authors.initials: MH
authors.lastname: Maor
authors.forename: L B
authors.initials: LB
authors.lastname: North
authors.forename: F F
authors.initials: FF
authors.lastname: Cabanillas
authors.forename: A L
authors.initials: AL
authors.lastname: Ames
authors.forename: M A
authors.initials: MA
authors.lastname: Hess
authors.forename: J D
authors.initials: JD
authors.lastname: Cox
mesh_terms: D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D007668:Kidney / Q000503:physiopathology / Q000528:radiation effects*; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000532:radiotherapy*; D018442:Lymphoma, B-Cell, Marginal Zone / Q000532:radiotherapy*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000532:radiotherapy*; D008297:Male; D008875:Middle Aged; D013274:Stomach Neoplasms / Q000532:radiotherapy*